Evidence map›Paper›PMID 29594950›Full record

ArticleHuman cell2018

The effect of human sperm chromatin maturity on ICSI outcomes.

Kamil Gill, Aleksandra Rosiak, Dariusz Gaczarzewicz, Joanna Jakubik, Rafal Kurzawa, Anna Kazienko, Anna Rymaszewska, Maria Laszczynska, Elzbieta Grochans, Malgorzata Piasecka

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Human cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04286633 (The Influence of Lead and Cadmium Seminal Plasma Level on Intracytoplasmic Sperm Injection), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04286633 unknown statusnot on this mapstarted 2022, after this paper: background citation

The Influence of Lead and Cadmium Seminal Plasma Level on Intracytoplasmic Sperm Injection (ICSI) Outcome

TypeobservationalSponsorAssiut UniversityRan2022 to 2022Enrolled50ConditionsInfertility, Male
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Paternal factors contributing to embryo quality.Journal of assisted reproduction and genetics · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Kamil GillDepartment of Histology and Developmental Biology, Pomeranian Medical University, Zolnierska 48, 71-210, Szczecin, Poland.
Aleksandra RosiakDepartment of Histology and Developmental Biology, Pomeranian Medical University, Zolnierska 48, 71-210, Szczecin, Poland.
Dariusz GaczarzewiczDepartment of Animal Reproduction, Biotechnology and Environmental Hygiene, West Pomeranian University of Technology, 71-270, Szczecin, Poland.
Joanna JakubikDepartment of Histology and Developmental Biology, Pomeranian Medical University, Zolnierska 48, 71-210, Szczecin, Poland.
Rafal KurzawaDepartment of Gynecology and Procreative Health, Pomeranian Medical University, 71-210, Szczecin, Poland.
Anna KazienkoDepartment of Histology and Developmental Biology, Pomeranian Medical University, Zolnierska 48, 71-210, Szczecin, Poland.
Anna RymaszewskaDepartment of Genetics, Faculty of Biology, University of Szczecin, 71-412, Szczecin, Poland.
Maria LaszczynskaDepartment of Histology and Developmental Biology, Pomeranian Medical University, Zolnierska 48, 71-210, Szczecin, Poland.
Elzbieta GrochansDepartment of Nursing, Pomeranian Medical University, 71-210, Szczecin, Poland.
Malgorzata PiaseckaDepartment of Histology and Developmental Biology, Pomeranian Medical University, Zolnierska 48, 71-210, Szczecin, Poland. mpiasecka@ipartner.com.pl.ORCID http://orcid.org/0000-0002-5914-2121
Pomeranian Medical University · PLUniversity of Szczecin · PLWest Pomeranian University of Technology in Szczecin · PL

Funding

Pomeranian Medical University FSN-322-5/2016Pomeranian Medical University WNoZ-322-04/S/2016
6 · The paper itself

Abstract

Because sperm chromatin may play a key role in reproductive success, we verify the associations between sperm chromatin abnormalities, embryo development and the ability to achieve pregnancy. The evaluation of sperm chromatin maturity using aniline blue (AB), chromomycin A3 (CMA3) and toluidine blue (TB) staining were carried out in group of males from infertile couples that underwent ICSI. Low levels of sperm chromatin abnormalities (< 16%) were found in most subjects (> 50%). A higher percentage of TB-positive sperm cells were discovered in the men from couples who achieved ≤ 50% fertilized oocytes compared to men who achieved > 50%. No significant differences were discovered by the applied tests between the men from couples who achieved ≤ 50% and those who achieved > 50% high-quality embryos on the 3rd or 5th day after fertilization, nor between the men from couples who achieved pregnancy and those who failed. The sperm chromatin maturity did not correlate with the ICSI results. However, the ROC analysis revealed a significant predictive value of TB-positive spermatozoa only for fertilization. Therefore, the TB assay can be considered as a useful test for the prediction of fertilization. Our findings suggest that the level of sperm chromatin abnormalities of the examined men was not clinically significant. No found associations between sperm chromatin maturity and embryo development and the ability to achieve pregnancy. We could not exclude the effects of the repairing processes in the fertilized oocyte. The use of complementary tests that verify the status of the sperm chromatin seems justified.

Indexed as

ChromatinSpermatozoaSperm Injections, IntracytoplasmicSperm MaturationAdultEmbryonic DevelopmentFemaleFertilization in VitroHumansInfertility, MaleMalePregnancyPregnancy OutcomeChromatinChromatinIn vitro fertilization (IVF)Male infertilitySperm

Identifiers

PMID29594950
OpenAlexW2796402813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.